TGA
- Status: likely_approved
Ojemda (TOVORAFENIB) regulatory status in Australia.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. TGA has authorised it; TGA has authorised it; TGA has authorised it.
Day One Biopharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.